Navigation Links
Microbia PE Bolsters Senior Management Team; Positions Company for Commercializing Proprietary Bioproducts
Date:12/17/2008

ok was most recently Director of Business Development at Synthetic Genomics, where she developed and negotiated research collaborations. Prior to that, Ms. Bok held various senior management positions including managing business development for Cabot Corporation, a global specialty chemical company. She holds an M.B.A. in Finance and International Management from MIT's Sloan School of Management.

Sam Zeller joins Microbia with a wealth of U.S. and international regulatory experience gained over two decades working with companies that produce biotechnology-based nutritional products. Prior to joining Microbia, he served as Director of Regulatory Affairs at Martek Biosciences Corporation, where he directed pre- and post-marketing activities and submissions for a variety of food ingredients, dietary supplements, and animal feed ingredients. Previously, he held various positions with responsibility for developing and implementing global regulatory strategy and ensuring quality, labeling, and advertising compliance for companies including OmegaTech and Nutrasweet Kelco. Dr. Zeller received a Ph.D. in Chemistry from the University of Minnesota.

ABOUT MICROBIAPE (www.microbia-pe.com)

Microbia is an industrial biotechnology company applying proprietary metabolic engineering approaches to create novel, commercially valuable specialty ingredients and biomaterials. Microbia's products are generated from renewable raw materials and either replace existing petrochemical-derived counterparts in a cost-effective manner, or introduce new industrial chemicals with applications as novel biomaterials. Microbia is commercializing its technology through internal product development programs as well as strategic alliances, including an ongoing multiproduct joint development and commercialization agreement with T
'/>"/>

SOURCE Microbia Precision Engineering, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. New Online Tutorial for the Comprehensive Microbial Resource (CMR)
2. PURE Bioscience and Ciba Strike New Contract for Natural Antimicrobial
3. Celsis Launches RapiScreen(TM) Beverage Microbial Screening System
4. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
5. 90 billion tons of microbial organisms live in the deep biosphere
6. Microtest Labs Doubles Microbial Identification, Analytical Services
7. Advanced Analytical Unveils New Instrument for Rapid Microbial Identification at BIO 2008
8. Microbia Announces Name Change to Ironwood Pharmaceuticals
9. New Microbial Genome-to-Array Service
10. Change in Medicare and Medicaid Legislation Creates Market for Antimicrobial Coatings In the U.S.
11. Baxter Receives 510(k) Clearance From FDA For V-Link With VitalShield, New Antimicrobial Intravascular Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Eppendorf has initiated an,import ban for ... for,infringement of European patent EP 1 179 ... the quantification of a target compound". The ... the respective products into any country of,the ... confiscate any,violating products. , ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) ... in research funding to support the ongoing development ... Muscular Dystrophy Association (MDA). This grant will ... and GMP manufacture of a drug candidate for ... not only provides important funding for Repligen,s research ...
(Date:12/15/2009)... for Atomic Force Microscopy (AFM) have been developed and ... at the liquid/air interface. The NeedleProbes’ cylindrical geometry enables ... rate and viscosity - all in a single force distance ... ... 2009 -- New, constant diameter NeedleProbes are enabling ...
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
Breaking Biology Technology:Eppendorf Successfully Initiates Import ban Against Nanosphere, Inc. for the Countries of the European Union 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 2New Constant Diameter NeedleProbes™ with Unique Ability to Measure Liquid Surface Properties by AFM 3Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2
... 29 United Therapeutics Corporation (Nasdaq: UTHR ... to its Board of Directors as an independent director. ... the financial sector. His areas of expertise include ... management. Prior to beginning a one-year sabbatical on ...
... delivery of ABthrax(TM) to U.S. Strategic National Stockpile -- $177 ... as of March 31, up $24 million from year-end 2008 ... of Albuferon (R) in chronic hepatitis C; ... Initiation of Syncria (R) Phase 3 program ...
... technology could transform agricultural advancement , ... ... AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical ... herbicide-tolerant trait to a specific, pre-determined location in the maize ...
Other Biology Technology:Richard Giltner Joins United Therapeutics Board of Directors 2Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 2Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 3Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 4Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 5Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 6Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 7Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 8Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 9Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments 10Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize 2Dow AgroSciences Confirms Efficacy of Zinc Finger Nucleases for Precise Genome Modification in Maize 3
(Date:12/16/2009)... Medicine researcher will lead the coordinating center for a ... field of stem cell research. Michael L. Terrin, M.D.,C.M.,M.P.H., ... the National Heart, Lung and Blood Institute (NHLBI) to ... which will be called the NHLBI Progenitor Cell Biology ... $30 million grant over seven years. , ...
(Date:12/16/2009)... and PALM HARBOR, Fla., Dec. 2 /PRNewswire-FirstCall/ ... Board: CICI), a leading supplier of electronic ... the financial industry* and the recognized leader** ... Inc. ("Docubase"), a leading International Electronic Document ... they have entered an agreement to provide ...
(Date:12/16/2009)... -- BIO-key International, Inc. (OTC Bulletin Board: ... solutions, today announced that SC Magazine, one ... named BIO-key International the 2009 Innovator of ... Biometrics. ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) ... SC Magazine, "Biometric providers have been trying ...
Breaking Biology News(10 mins):University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 2BIO-key(R) Selected as 2009 Industry Innovator in Biometrics by SC Magazine 3Yerkes researchers present at 39th Annual Society for Neuroscience Conference 59660 1Yerkes researchers present at 39th Annual Society for Neuroscience Conference 59660 2Yerkes researchers present at 39th Annual Society for Neuroscience Conference 59660 3Yerkes researchers present at 39th Annual Society for Neuroscience Conference 59660 4Yerkes researchers present at 39th Annual Society for Neuroscience Conference 59660 5New FDA Study Seeks Feedback on Lasik Surgery 59656 1New FDA Study Seeks Feedback on Lasik Surgery 59656 2Stem Cell and PRP Therapy for Orthopedic Conditions 59651 1Stem Cell and PRP Therapy for Orthopedic Conditions 59651 2Stem Cell and PRP Therapy for Orthopedic Conditions 59651 3
... rights to a new owl butterfly species discovered at ... $40,800, with proceeds benefiting continued research on Mexican butterflies. ... and Andrew Warren discovered the new butterfly from Mexicos ... this weeks issue of the Bulletin of the Allyn ...
... A joint Yale-Peking University center that aims to improve ... receive five years of continued and expanded support from ... , The company will fund student exchanges and a ... Joint Center (PYC) for Plant Molecular Genetics and Agrobiotechnology ...
... small amounts of lead in children,s blood -- amounts ... with reduced IQ scores, finds a new six-year Cornell ... on cognitive function in children whose blood-lead levels (BLLs) ... (CDC) standard of 10 micrograms per deciliter (mcg/dl) -- ...
Other Biology News:UF's new owl butterfly species naming rights auctioned for $40,800 2UF's new owl butterfly species naming rights auctioned for $40,800 3Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center 2Even minute levels of lead cause brain damage in children 2